Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07491393 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology

Name: Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology — clinical trial record (NCT07491393)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NEFOPAIN kinet

StatusNot Yet Recruiting

PhasePhase 4

SponsorUniversity Hospital, Rouen

Started2026-04-01

View on ClinicalTrials.gov ↗

University Hospital, Rouen

259 trials monitored

See all monitored trials

Nefopam is a non-opioid analgesic approved for the symptomatic treatment of acute pain, particularly postoperative pain. The HAS has authorized nefopam tablet, while emphasizing the lack of bibliographic data on both the pharmacokinetic and clinical aspects. The aim of this study is to evaluate the pharmacokinetics of nefopam tablets.

Trial Details

NCT Number	NCT07491393
Lead Sponsor	University Hospital, Rouen
Conditions	Acute Rheumatic Pain
Enrollment	24 participants
Start Date	2026-04-01
Primary Completion	2027-04-07 (estimated)
Study Completion	2027-04-07 (estimated)
Updated on ClinicalTrials.gov	2026-03-24